Laquinimod, a Quinoline-3-Carboxamide, Induces Type II Myeloid Cells That Modulate Central Nervous System Autoimmunity
Ulf Schulze‐Topphoff(Novartis (Germany)), Scott S. Zamvil(University of California, San Francisco)
Cited by 97
Related Papers
Type II monocytes modulate T cell–mediated central nervous system autoimmune disease
|Nature Medicine|2007|448
Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration
|Nature Immunology|2018|210
Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation
|Nature Immunology|2020|202
Defining blood-induced microglia functions in neurodegeneration through multiomic profiling
|Nature Immunology|2023|126
Restoring immune tolerance in neuromyelitis optica
|Neurology Neuroimmunology & Neuroinflammation|2016|57